The contents of this three page letter could have dramatic consequences for the legal status of cannabis in the eyes of international law.
European savers will soon be offered their first opportunity to invest in an exchange traded fund focused on the fast-growing legal marijuana industry. Canadian fund group Purpose Investments plans to launch the Medical Cannabis and Wellness ETF from January 13, which will be Europe’s first such product.
Although EFSA’s Novel Food Catalogue is merely advisory, domestic regulators rely on it for guidance and are likely to act first, ask questions later.
The medical use of preparations derived from the Cannabis sativa plant has a long history.